Revelation Biosciences, Inc.
REVBNASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $2.92M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.71$5.80
- Volume (live)
- -
- Avg. volume (3M)
- 51.74K
Revelation Biosciences (REVB) Stock Price & Financial Analysis
Revelation Biosciences Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $0.47 - $0.71 |
|---|---|
| 52-Week High | $5.80 |
| 52-Week Low | $0.71 |
| Open | $0.71 |
| Volume (last close) | 623.90K |
| Average Volume (3M) | 51.74K |
| 50-Day MA | $0.96 |
|---|---|
| 200-Day MA | $1.34 |
| 1-Year Change | −40.91% |
| Market Cap | 2.92M |
|---|---|
| Shares Outstanding | 3.83M |
| Price to Book (P/B) | 0.29 |
| EV/EBITDA | 0.72 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Revelation Biosciences at a Glance
As of the Oct 16, 2026 close, Revelation Biosciences (REVB) has a market capitalization of $2.92M. Revenue fell 100.0% year over year.
As of its latest reported balance sheet, it holds $11.48M in cash and securities against $739.92K of debt, a net cash position of $10.74M.
Revelation Biosciences does not currently pay a dividend.
The share price is down 40.9% over the past year. At $0.48 (the Oct 16, 2026 close) it sits near the bottom of its 52-week range of $0.71 to $5.80, below its 200-day moving average of $1.34.
Frequently Asked Questions About Revelation Biosciences
What is the current stock price for REVB?
As of the Oct 16, 2026 close, REVB stock trades at $0.48. The 52-week range is $0.71–$5.80, with a day range of $0.47–$0.70.
What is the P/E ratio for REVB?
The P/E ratio (Price-to-Earnings) for REVB is shown in the Key Statistics section. This valuation metric helps compare Revelation Biosciences, Inc. to industry peers.
Does REVB pay dividends?
Revelation Biosciences does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for REVB?
Analyst ratings and recommendations for REVB are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of REVB?
As of the Oct 16, 2026 close, Revelation Biosciences's market capitalization is $1.9M, classifying it as a micro-cap company. Revelation Biosciences operates in the Healthcare sector within the Biotechnology industry.